Gerresheimer: FDA grants tentative approval of SQ innovation’s Lasix ONYU
Patented device technology for precise administration
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Gerresheimer
Gerresheimer completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma…
The acquisition creates a new moulded glass unit with a diversified product portfolio for the pharmaceutical, cosmetics, food and…
Gerresheimer to acquire Blitz LuxCo Sarl, for EUR 800 million
Aquisition strengthens Gerresheimer’s position as a full - service provider in the pharma industry
Gerresheimer and Corning announce JV for Velocity Vials
Compared with conventional vials, Velocity Vials can also protect against damage that could lead to particles, breaks, and cracks
Gerresheimer launches new Clinical Trial Kit
It can be ordered in six different configurations of Gx RTF Glass Vials
CDP score: Gerresheimer upgraded to “A-” for performance on climate change
Gerresheimer has participated in CDP’s annual detailed and independent assessment of companies on climate change since 2011 and…
Gerresheimer and Zollner enter into strategic partnership for electronically controlled medtech…
The two companies tap into growing demand for digital and connected drug delivery and diagnostic systems
Gerresheimer boosts global production capabilities with new facilities in India
By adding capacities in India, Gerresheimer intends to ensure consistent supply for critical pharma and healthcare facilities…
Gerresheimer’s global pharma business develops well during COVID-19 pandemic
The company generates revenue of EUR 363 million in the second quarter of 2020 Gerresheimer generated revenues of EUR 363…
Gerresheimer launches eye opener
It ensures easy use and correct positioning of eye droppers